Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen - TILIA

Inclusion Criteria

• - Adult participants ≥ 18 years old at the time of signing the informed consent form.
• - Patients hospitalised with viral lung infection.
• - Hypoxaemia requiring treatment with supplemental O2.
• Hypoxaemia is defined as:
• SpO2 ≤ 90% OR
• SpO2 ≤ 92% AND one or both of the following:
• Radiographic infiltrates by CXR/CT compatible with viral lung infection per investigator judgement.
• Use of accessory muscles of respiration or RR (respiratory rate) > 22.
• - Patient remains hypoxaemic at randomisation requiring treatment with supplemental oxygen.